financetom
Business
financetom
/
Business
/
Atlas Lithium More Than Doubles Exploration Portfolio in Brazil With New Lithium Mineral Rights
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Atlas Lithium More Than Doubles Exploration Portfolio in Brazil With New Lithium Mineral Rights
Jun 17, 2024 9:34 AM

12:28 PM EDT, 06/17/2024 (MT Newswires) -- Atlas Lithium ( ATLX ) said Monday that it secured new lithium mineral rights in Brazil, more than doubling its lithium exploration portfolio in the country to about 133,294 acres.

The company also said it has completed trial assembly at the dense media separation plant to produce lithium concentrate. The plant is being geared up for shipment to site in Q3 as Atlas Lithium ( ATLX ) targets to start its Neves lithium project's commissioning and production in Q4, according to the statement.

Price: 10.12, Change: -0.04, Percent Change: -0.39

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chevron expects up to $400 million quarterly impact from Hess deal
Chevron expects up to $400 million quarterly impact from Hess deal
Sep 25, 2025
Sept 25 (Reuters) - Chevron ( CVX ) said on Thursday it was expecting a loss of $200 million to $400 million in the third quarter due to the impact related to the acquisition of Hess. Chevron ( CVX ) closed its $55 billion buyout of Hess in July after winning a landmark legal battle against larger rival Exxon Mobil...
Eli Lilly Stops Diabetes Trial Studying Weight Loss in Obese Patients
Eli Lilly Stops Diabetes Trial Studying Weight Loss in Obese Patients
Sep 25, 2025
08:17 AM EDT, 09/25/2025 (MT Newswires) -- Eli Lilly ( LLY ) has stopped its study evaluating the impact of bimagrumab and tirzepatide, alone or in combination, in lowering body weight in obesity patients with type 2 diabetes, an update from the US registry of clinical trials showed Wednesday. The study was terminated for strategic business reasons, the website showed....
UnitedHealth Unit, CNSide Diagnostics Sign National Coverage Deal for Tumor Cell Lab Test
UnitedHealth Unit, CNSide Diagnostics Sign National Coverage Deal for Tumor Cell Lab Test
Sep 25, 2025
08:13 AM EDT, 09/25/2025 (MT Newswires) -- UnitedHealth Group ( UNH ) subsidiary UnitedHealthcare Insurance and Plus Therapeutics' ( PSTV ) CNSide Diagnostics unit have entered into a national coverage deal to offer the the CNSide cerebrospinal fluid tumor cell enumeration laboratory developed test, CNSide said Thursday. The deal, effective Sept. 15, covers more than 51 million people in the...
Brookfield Business Partners to Merge With Brookfield Business Corporation into Single Public Entity
Brookfield Business Partners to Merge With Brookfield Business Corporation into Single Public Entity
Sep 25, 2025
08:13 AM EDT, 09/25/2025 (MT Newswires) -- Brookfield Business Partners ( BBU ) said Thursday that it has approved plans to simplify its corporate structure by merging Brookfield Business Partners LP ( BBU ) and Brookfield Business Corporation ( BBUC ) into a single publicly traded Canadian corporation called BBU Inc. The company said Brookfield Business Corporation ( BBUC )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved